Strasbourg
France
38
2012-02-16
34
2013-09-24
These are the the leading inventors for applications assigned to TRANSGENE S.A.:
TRANSGENE S.A. based in Strasbourg, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
#2 | 2010-12-30 ✅ Patent 8,257,692 granted on 2012-09-04Polypeptide having an improved cytosine deaminase activity
#3 | 2010-12-30 ✅ Patent 8,226,954 granted on 2012-07-24Polypeptide having an improved cytosine deaminase activity
#4 | 2010-12-02 ✅ Patent 8,337,859 granted on 2012-12-25Vectors for multiple gene expression
#5 | 2010-07-08 ✅ Patent 9,024,003 granted on 2015-05-05Avian telomerase reverse transcriptase
#6 | 2010-06-24 ✅ Patent 8,415,462 granted on 2013-04-09Signaling peptides
#7 | 2010-05-27RECOMBINANT VIRAL VACCINE
#8 | 2010-01-14 ✅ Patent 8,057,162 granted on 2011-11-15Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
#9 | 2009-07-23 ✅ Patent 8,211,444 granted on 2012-07-03Hepatitis C virus non structural fusion protein
#10 | 2009-07-14 ✅ Patent 7,560,527 granted on 2009-07-14Modified adenovirus fibre and uses
#11 | 2009-07-02 ✅ Patent 8,470,591 granted on 2013-06-25Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal
#12 | 2009-04-23 ✅ Patent 7,670,607 granted on 2010-03-02Pharmaceutical compositions for treating papillomavirus tumors and infection
#13 | 2009-01-27 ✅ Patent 7,482,155 granted on 2009-01-27Chimeric promoters for controlling expression in smooth muscle cells
#14 | 2008-04-08 ✅ Patent 7,354,591 granted on 2008-04-08Poxvirus with targeted infection specificity
#15 | 2007-11-22 ✅ Patent 7,695,960 granted on 2010-04-13Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
#16 | 2007-11-15 ✅ Patent 7,790,445 granted on 2010-09-07Polypeptide having an improved cytosine deaminase activity
#17 | 2007-09-04 ✅ Patent 7,264,958 granted on 2007-09-04Method for obtaining a purified viral preparation
#18 | 2007-05-17 ✅ Patent 7,534,585 granted on 2009-05-19Multifunctional cytokines
#19 | 2007-03-22 ✅ Patent 7,488,482 granted on 2009-02-10Pharmaceutical compositions for treating papillomavirus tumors and infection
#20 | 2006-10-10 ✅ Patent 7,118,754 granted on 2006-10-10Pharmaceutical composition for treating papillomavirus tumors and infection
#21 | 2006-07-27 ✅ Patent 7,378,265 granted on 2008-05-27Method of inactivating enveloped viruses in a viral preparation of non-enveloped viruses
#22 | 2006-06-29Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain
#23 | 2006-06-27 ✅ Patent 7,067,310 granted on 2006-06-27Method for the preparation of a viral vector by inter-molecular homologous recombination
#24 | 2006-06-27 ✅ Patent 7,067,309 granted on 2006-06-27Defective adenoviruses and corresponding complementation lines
#25 | 2006-06-22Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
#26 | 2006-05-25 ✅ Patent 7,572,438 granted on 2009-08-11Mutant having uracil phosphoribosyl transferase activity
#27 | 2006-05-23 ✅ Patent 7,049,117 granted on 2006-05-23Mutant possessing uracil phosphoribosyl transferase activity
#28 | 2006-04-25 ✅ Patent 7,033,779 granted on 2006-04-25Method for preparing steroids modified by yeast fermentation
#29 | 2006-04-11 ✅ Patent 7,026,299 granted on 2006-04-11Connective tissue growth factor-2
#30 | 2006-04-11 ✅ Patent 7,026,154 granted on 2006-04-11Method of inactivating enveloped viruses in a viral preparation of non-enveloped viruses
#31 | 2006-03-09Connective tissue growth factor-2
#32 | 2006-02-28 ✅ Patent 7,005,277 granted on 2006-02-28Defective adenoviruses and corresponding complementation lines
#33 | 2005-09-22 ✅ Patent 7,348,014 granted on 2008-03-25Poxvirus with targeted infection specificity
#34 | 2005-07-21 ✅ Patent 7,332,478 granted on 2008-02-19Antitumoral composition based on immunogenic polypeptide with modified cell location
#35 | 2005-06-14 ✅ Patent 6,906,041 granted on 2005-06-14Treatment of immune diseases
#36 | 2005-04-26 ✅ Patent 6,884,786 granted on 2005-04-26Antitumoral composition based on immunogenic polypeptide with modified cell location
#37 | 2005-04-19 ✅ Patent 6,881,724 granted on 2005-04-19Use of magnesium (Mg2+) for the preparation of a therapeutic composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy
#38 | 2005-03-24 ✅ Patent 7,608,267 granted on 2009-10-27Multifunctional cytokines
176526 ⎘